<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03362424</url>
  </required_header>
  <id_info>
    <org_study_id>2.335.243</org_study_id>
    <nct_id>NCT03362424</nct_id>
  </id_info>
  <brief_title>Mesenchymal Stem Cells in Rotator Cuff Repair</brief_title>
  <official_title>Mesenchymal Stem Cells in Rotator Cuff Repair - a Randomized Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized clinical study involving 44 patients, evaluating the effect of mesenchymal cells&#xD;
      on rotator cuff repair. The primary outcome will be post-operative MRI tendon integrity and&#xD;
      secondary outcomes clinical assessment by the UCLA and American Shoulder and Elbow Surgeons&#xD;
      (ASES) scales and pain by visual analog scale (VAS).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rotator cuff tendinopathy is the main cause of shoulder pain and tear of these tendons&#xD;
      affects 20% of the population. Although arthroscopic repair leads to satisfactory clinical&#xD;
      results, the retear rates varies from 4 to 94%. The main cause of failure after rotator cuff&#xD;
      repair is not related to the material used, but to the tissue deficiency and the healing&#xD;
      process between the tendon and the bone. After the intervention, the rotator cuff does not&#xD;
      restore its original histological characteristics and its fixation occurs through scar tissue&#xD;
      with lower biomechanical resistance. There are few clinical studies on the use of mesenchymal&#xD;
      cells in rotator cuff repair,, with good results.&#xD;
&#xD;
      The investigators will perform a randomized clinical study involving 44 patients, evaluating&#xD;
      the effect of mesenchymal cells on rotator cuff repair. The primary outcome will be&#xD;
      post-operative MRI tendon integrity and secondary outcomes clinical assessment by the UCLA&#xD;
      and American Shoulder and Elbow Surgeons (ASES) scales and pain by visual analog scale (VAS).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2023</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Surgeon and patients not blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>MRI integrity</measure>
    <time_frame>6 months</time_frame>
    <description>Sugaya classification</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES)</measure>
    <time_frame>6, 12 and 24-months</time_frame>
    <description>minimum 0 points, maximum 100 points. Higher values are considered best outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>University at California at Los Angeles Shouder Rating Scale (UCLA)</measure>
    <time_frame>6, 12 and 24-months</time_frame>
    <description>minimum 3 points, maximum 35 points. Higher values are considered best outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale for Pain (VAS)</measure>
    <time_frame>6, 12 and 24-months</time_frame>
    <description>miminum 0 points, maximum 10 points. Higher values are considered worst outcomes.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Rotator Cuff Tear</condition>
  <condition>Tendon Injuries</condition>
  <condition>Mesenchymal Stem Cell</condition>
  <arm_group>
    <arm_group_label>Mesenchymal stem cell group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rotator cuff repair stem cells</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>rotator cuff repair</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Mesenchymal stem cell</intervention_name>
    <description>Mesenchymal stem cells applies at the end of rotator cuff repair in de active group</description>
    <arm_group_label>Mesenchymal stem cell group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rotator cuff repair</intervention_name>
    <description>Rotator cuff repair</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Mesenchymal stem cell group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Full thickness posterosuperior rotator cuff tear, of small or medium size, fully&#xD;
             repairable at the time of surgery, regardless of size;&#xD;
&#xD;
          -  Pain and / or decreased shoulder function for at least 3 months, with no improvement&#xD;
             with non-surgical treatment;&#xD;
&#xD;
          -  Absence of the following changes in MRI:&#xD;
&#xD;
          -  Fat degeneration of the rotator cuff musculature of grade 3 according to the&#xD;
             classification of Fuchs (presence of equal or superior amount of fat compared to&#xD;
             muscle fibers);&#xD;
&#xD;
          -  Absence of the following changes in radiographs&#xD;
&#xD;
          -  Advanced glenohumeral arthrosis (grades 2, 3 and 4 of Samilson and Prieto&#xD;
&#xD;
          -  Signs of rotator cuff arthropathy, according to Seebauer classification;&#xD;
&#xD;
          -  Skeletal maturity;&#xD;
&#xD;
          -  Absence of surgeries or previous fractures in the shoulder in question;&#xD;
&#xD;
          -  Absence of psychiatric illnesses, fibromyalgia or painful pathologies of the cervical&#xD;
             spine;&#xD;
&#xD;
          -  Absence of rheumatic diseases or chronic use of corticosteroids;&#xD;
&#xD;
          -  Absence of active or recent infection;&#xD;
&#xD;
          -  Absence of thrombocytopenia, coagulopathies or chronic use of anticoagulants;&#xD;
&#xD;
          -  Absence of vascular or neurological lesions affecting the upper limb;&#xD;
&#xD;
          -  Absence of pregnancy;&#xD;
&#xD;
          -  Clinical non-compensated comorbidities;&#xD;
&#xD;
          -  Chronic use of corticosteroids;&#xD;
&#xD;
          -  Consent to free and informed consent;&#xD;
&#xD;
          -  Live in Brazil.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Visualization during the operative event of one or more of the findings:&#xD;
&#xD;
          -  Irreparable rupture of rotator cuff;&#xD;
&#xD;
          -  Subsecapularis tear involving two thirds or more of its extension;&#xD;
&#xD;
          -  Need to open surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>EDUARDO ANGELI MALAVOLTA A Malavolta, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MD, PhD, Associate Professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eduardo A Malavolta, PhD</last_name>
    <phone>+5511998329862</phone>
    <email>eduardomalavolta@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thais P Vasques</last_name>
    <phone>+5511 2661-2486</phone>
    <email>thaiscpvasques@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universidade de São Paulo</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <zip>05403-010</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo A Malavolta, PhD</last_name>
      <phone>+5511998329862</phone>
      <email>eduardomalavolta@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Thais Vasques</last_name>
      <phone>+551126612486</phone>
      <email>thaiscpvasques@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 29, 2017</study_first_submitted>
  <study_first_submitted_qc>December 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 5, 2017</study_first_posted>
  <last_update_submitted>April 28, 2021</last_update_submitted>
  <last_update_submitted_qc>April 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Eduardo Angeli Malavolta</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rotator Cuff Injuries</mesh_term>
    <mesh_term>Tendon Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

